ClinicalTrials.gg
RecruitingNCT07729488Updated Sep 21, 2026

ESPB Versus SPSIPB for Quality of Recovery After Video-Assisted Thoracoscopic Surgery

An interventional study of ESPB and SPSIPB in Postoperative Pain, sponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Video-assisted thoracoscopic surgery (VATS) is associated with moderate to severe postoperative pain despite its minimally invasive nature. Ultrasound-guided erector spinae plane block (ESPB) and serratus posterior superior intercostal plane block (SPSIPB) are promising regional analgesic techniques for thoracic surgery; however, evidence directly comparing their effects on postoperative quality of recovery remains limited. This prospective, randomized, double-blind controlled trial aims to compare the effects of ESPB and SPSIPB on postoperative quality of recovery, measured by the Quality of Recovery-15 (QoR-15) questionnaire at 24 hours after surgery. Secondary outcomes include postoperative pain scores, tramadol consumption, time to first rescue analgesia, rescue analgesic requirement, postoperative nausea and vomiting, patient satisfaction, length of hospital stay, block-related complications, and perioperative hemodynamic parameters.

Read the detailed description

Video-assisted thoracoscopic surgery (VATS) has become the preferred surgical approach for many thoracic procedures because of its minimally invasive nature. Nevertheless, patients frequently experience moderate to severe postoperative pain, which may impair respiratory function, delay mobilization, prolong hospitalization, and negatively affect overall recovery. Effective multimodal analgesia is therefore essential for optimizing postoperative outcomes.

Ultrasound-guided erector spinae plane block (ESPB) and serratus posterior superior intercostal plane block (SPSIPB) are interfascial plane blocks that have demonstrated promising analgesic efficacy in thoracic surgery. Although both techniques are increasingly used in clinical practice, evidence directly comparing their effects on postoperative quality of recovery following VATS is limited.

This prospective, randomized, double-blind, parallel-group clinical trial will enroll 128 adult patients (18-70 years, ASA physical status I-III) undergoing elective VATS. Participants will be randomly assigned in a 1:1 ratio to receive either ultrasound-guided ESPB or ultrasound-guided SPSIPB before surgery.

The primary outcome is the Quality of Recovery-15 (QoR-15) score at 24 hours after surgery. Secondary outcomes include postoperative pain scores at rest and during coughing, cumulative 24-hour tramadol consumption, time to first rescue analgesia, rescue analgesic requirement, postoperative nausea and vomiting, sedation level, patient satisfaction, length of hospital stay, block-related complications, perioperative hemodynamic variables, and additional analgesic requirements.

The results of this study are expected to provide high-quality evidence regarding the comparative effectiveness of ESPB and SPSIPB in improving postoperative recovery and analgesic outcomes after VATS and may contribute to optimizing regional analgesia strategies for thoracic surgery.

02

Conditions studied

  • Postoperative Pain

Browse trials for

03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 128 is above the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital is the lead sponsor of 59 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18-85 years.
  • I-III.
  • Scheduled for elective VATS under general anesthesia.
  • Able to understand and complete the QoR-15 questionnaire.
  • Written provided.

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate or inability to provide written .
  • Known allergy or to bupivacaine, paracetamol, dexketoprofen, or tramadol.
  • Infection at the planned block injection site.
  • Coagulopathy or ongoing anticoagulant therapy precluding regional anesthesia.
  • Severe hepatic or renal insufficiency.
  • Chronic opioid use or chronic pain requiring regular analgesic treatment.
  • Previous thoracic surgery on the operative side.
  • Pregnancy or breastfeeding.
  • Cognitive impairment, psychiatric illness, or language barrier preventing completion of the QoR-15 questionnaire.
  • (BMI) >35 kg/m².
  • Conversion from VATS to thoracotomy.
  • Failed or incomplete regional block.
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Ultrasound-Guided Erector Spinae Plane Block (ESPB)

    An ultrasound-guided erector spinae plane block (ESPB) will be performed before induction of general anesthesia using 30 mL of 0.25% bupivacaine for postoperative analgesia in patients undergoing elective video-assisted thoracoscopic surgery (VATS).

    Procedure: ESPB

  • Experimental
    Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block

    An ultrasound-guided serratus posterior superior intercostal plane block (SPSIPB) will be performed before induction of general anesthesia using 30 mL of 0.25% bupivacaine for postoperative analgesia in patients undergoing elective video-assisted thoracoscopic surgery (VATS).

    Procedure: SPSIPB

Interventions

  • ProcedureESPB

    An ultrasound-guided erector spinae plane block will be performed preoperatively for postoperative analgesia in patients undergoing elective video-assisted thoracoscopic surgery. The block will be performed using the standardized study protocol.

    Also known as: Ultrasound-Guided Erector Spinae Plane Block

  • ProcedureSPSIPB

    An ultrasound-guided serratus posterior superior intercostal plane block will be performed preoperatively for postoperative analgesia in patients undergoing elective video-assisted thoracoscopic surgery. The block will be performed using the standardized study protocol.

    Also known as: Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block

06

What researchers measure

Primary outcomes

  1. Quality of Recovery-15 (QoR-15) Score

    Postoperative quality of recovery will be assessed using the validated Turkish version of the Quality of Recovery-15 questionnaire. The total score ranges from 0 to 150, with higher scores indicating better recovery. The preoperative QoR-15 score will be recorded as a baseline measurement and considered in the analysis of the postoperative 24-hour score.

    Time frame: 24 hours after surgery

Secondary outcomes

  1. Postoperative Pain at Rest

    Postoperative pain intensity at rest will be assessed using an 11-point Numerical Rating Scale (NRS), with scores ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours after surgery.

  2. Postoperative Pain Intensity During Coughing

    Postoperative pain intensity during coughing will be assessed using an 11-point Numerical Rating Scale (NRS), with scores ranging from 0 (no pain) to 10 (worst imaginable pain).

    Time frame: 30 minutes, 2 hours, 6 hours, 12 hours, and 24 hours after surgery.

  3. Time to First Rescue Analgesia

    The time from arrival in the post-anesthesia care unit (PACU) to the first administration of rescue analgesia will be recorded in minutes.

    Time frame: During the first 24 hours after surgery

  4. Cumulative Postoperative Tramadol Consumption

    The total amount of tramadol administered for postoperative rescue analgesia during the first 24 hours after surgery will be recorded in milligrams (mg).

    Time frame: During the first 24 hours after surgery

  5. Requirement for Rescue Analgesia

    The proportion of participants requiring at least one dose of rescue analgesia during the first 24 hours after surgery will be recorded.

    Time frame: During the first 24 hours after surgery

  6. Postoperative Nausea and Vomiting Impact Score

    Postoperative nausea and vomiting will be assessed using the Simplified Postoperative Nausea and Vomiting Impact Scale. The scale combines the number of vomiting episodes and the perceived impact of nausea on recovery, with a total score ranging from 0 to 6. Higher scores indicate a greater impact of postoperative nausea and vomiting, and a score of 5 or greater indicates clinically important PONV.

    Time frame: During the first 24 hours after surgery

  7. Patient Satisfaction With Postoperative Analgesia

    Patient satisfaction with postoperative pain management will be assessed using a 5-point Likert scale, where 1 = very dissatisfied, 2 = dissatisfied, 3 = neither satisfied nor dissatisfied, 4 = satisfied, and 5 = very satisfied. Higher scores indicate greater patient satisfaction.

    Time frame: 24 hours after surgery

  8. Postoperative Length of Hospital Stay

    Postoperative length of hospital stay will be recorded as the number of days from surgery until hospital discharge.

    Time frame: From surgery until hospital discharge (up to 30 days)

  9. Incidence of Block-Related Complications

    The incidence of block-related complications, including local anesthetic systemic toxicity, pneumothorax, hematoma, infection, vascular puncture, and other procedure-related adverse events, will be recorded.

    Time frame: From block performance until hospital discharge (up to 30 days)

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07729488
Lead sponsor
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Responsible party
Fatma Acil,MD (Principal Investigator, Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital) — Principal investigator
First posted
Jul 27, 2026
Start date
Sep 16, 2026
Primary completion
Dec 29, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Sep 21, 2026

Study contacts

Fatma Acil, M.D.
Contact
acilfatma@gmail.com
+905337225225
Andaç Dedeoğlu, M.D.
Contact
anderen77@hotmail.com
+905326848626
Fatma Acil, M.D.
principal investigator · Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion